hair loss on glp-1 has increasingly been reported among patients using and GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed Hair loss from GLP-1 Injections

for 14 days with ferroptosis inhibitor (3 mg/kg Fer-1) before KA administration

The CONQUER study enrolled 2,487 overweight and obese adults, with participants receiving high-dose Qsymia (15mg phentermine/92mg topiramate) achieving 10.2% weight loss compared to 1.8% with placebo

Avoid repeated freeze-thaw cycles, which can promote disulfide rearrangement and loss of the cyclic structure

The CBLIF gene is located on chromosome 11q12.1 and is composed of 9 exons that encode a 417 amino acid precursor protein

Additionally, phentermine is a Schedule IV controlled substance with a typical recommendation of short-term use (12 weeks or less), while semaglutide is designed for long-term chronic weight management